Skip to main
MDGL

Madrigal Pharmaceuticals (MDGL) Market Capitalization Overview

Market Cap: $13.49B as of Jan 2, 2026

$13.49B
$317.51M (2.41%)past month
As of Jan 2, 2026, Madrigal Pharmaceuticals (MDGL) has a market capitalization of $13.49B. Over the past 30 days, its market cap has increased by 2.49%, while in the last 12 months, it has increased by 1.98%.

Market capitalization represents the total value of Madrigal Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Madrigal Pharmaceuticals (MDGL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Madrigal Pharmaceuticals (MDGL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Madrigal Pharmaceuticals (MDGL) Market Cap History

DateMarket CapChange
Dec 1, 2025$13.17B+43.19%
Nov 3, 2025$9.20B-8.19%
Oct 1, 2025$10.02B+2.99%
Sep 2, 2025$9.73B+44.88%
Aug 1, 2025$6.71B+0.67%
Jul 1, 2025$6.67B+10.08%
Jun 2, 2025$6.06B-16.33%
May 1, 2025$7.24B+1.15%
Apr 1, 2025$7.16B+3.35%
Mar 3, 2025$6.93B-2.50%
Feb 3, 2025$7.10B+3.73%
Jan 2, 2025$6.85B-1.50%

Madrigal Pharmaceuticals (MDGL) End of Year Market Cap History

DateMarket CapChange
2026$13.49B+1.98%
2025$13.23B+96.52%
2024$6.74B+47.33%
2023$4.57B-7.98%
2022$4.97B+242.64%
2021$1.45B

FAQs About Madrigal Pharmaceuticals (MDGL) Market Cap

As of Jan 2, 2026, the market capitalization of Madrigal Pharmaceuticals (MDGL) is $13.49B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Madrigal Pharmaceuticals’s market capitalization has increased by 2.41%, changing from $13.18B to $13.49B as of Jan 2, 2026.

In the last 3 months, Madrigal Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Madrigal Pharmaceuticals’s market capitalization increased from $6.74B in January to $13.23B in December, reflecting a 96.52% change.

In the past five years, Madrigal Pharmaceuticals (MDGL) has had a compound annual growth rate (CAGR) of 55.63% in market capitalization. This means its market cap has grown at an average rate of 55.63% per year.

Madrigal Pharmaceuticals (MDGL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.